Grand Hôpital De Charleroi

Diffuse large B-cell lymphoma often responds to standard chemo-immunotherapy, but roughly a third of patients do not respond or relapse early. Researchers at the Grand Hôpital de Charleroi are testing machine learning algorithms to predict which patients are likely to be primary …

This study tests a wearable device called Japet.W+ that supports the lower back during physiotherapy. Sixty adults with non-specific mechanical low back pain lasting more than 6 weeks will be split into two groups: one doing physiotherapy with the device, the other without. Resea…

This study tests an artificial intelligence system designed to predict when lymphoma patients might not take their oral medications as prescribed. Researchers will enroll 210 adults with non-Hodgkin lymphoma and use AI to analyze patient data, aiming to catch non-compliance early…

This study follows 100 stroke survivors with arm weakness to see how their own sense of arm use changes during intensive rehab. Researchers compare patients' perceptions with actual arm function using standard tests. The goal is to better understand the gap between what patients …